{"id":21036,"date":"2014-05-02T12:40:00","date_gmt":"2014-05-02T16:40:00","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=21036"},"modified":"2014-05-02T12:40:00","modified_gmt":"2014-05-02T16:40:00","slug":"astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036","title":{"rendered":"Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0<b>AstraZeneca plc (ADR) (NYSE:AZN)<\/b> declined <b>Pfizer Inc. (NYSE:PFE) <\/b>within hours of reception, claiming the offer to be too low.<\/p>\n<p style=\"text-align: justify;\"><b>A Raised Bid<\/b><\/p>\n<p style=\"text-align: justify;\">On Friday, Pfizer\u2019s attempt to acquire AstraZeneca was expected to draw to a close as it offered an increased bid of $106.5 billion to the UK based shareholders group. However, the bid was rejected as AstraZeneca\u2019s board found the bid of the world\u2019s largest pharmaceutical company too low. The earlier January offer was 46.61 pounds, which was increased 50 pounds per share on Friday. This had lead AstraZeneca to connect with Pfizer for the first time in the four month chase. The increased offer price additionally included a 32%, from the previous 30%, cash component.<\/p>\n<p style=\"text-align: justify;\">AstraZeneca plc (ADR) (NYSE:AZN)\u2019s Chairman, Leif Johansson, said that the board rejected the offer without any hesitation as the offer threatened the company to dilute its shareholders\u2019 exposure to its unique product pipeline. It risked the company around its deliver, he said. Pfizer had earlier affirmed its commitment to the development of UK Science by writing to the state\u2019s Prime Minister, David Cameron. It had pledged to construct AstraZeneca\u2019s new flagship facility for research and development in Cambridge.<\/p>\n<p style=\"text-align: justify;\"><b>\u201cDevastating Blow\u201d<\/b><\/p>\n<p style=\"text-align: justify;\">It is speculated that any probable merger would be the biggest foreign acquisition for a company based in UK, despite the fact that AstraZeneca plc (ADR) (NYSE:AZN) itself has been formed from an international tie- up. In this context, the government of UK seemed to be dormant in taking actions against the merger. It, however, sought to ensure commitment for development of the state\u2019s science. A former science minister, Lord Sainsbury, is strongly against the merger and said that the tie- up would be a highly upsetting move for UK science.<\/p>\n<p style=\"text-align: justify;\">In a statement, AstraZeneca plc (ADR) (NYSE:AZN)\u2019s spokeswoman said that the board will discuss the offer at appropriate time, while affirming the reception of the offer from Pfizer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0AstraZeneca plc (ADR) (NYSE:AZN) declined Pfizer Inc. (NYSE:PFE) within hours of reception, claiming the offer to be too low. A Raised [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":20478,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[4503,4504,993,2745],"stock_ticker":[],"class_list":["post-21036","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-astrazeneca-plc-adr-nyseazn","tag-nyseazn","tag-nysepfe","tag-pfizer-inc-nysepfe","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0AstraZeneca plc (ADR) (NYSE:AZN) declined Pfizer Inc. (NYSE:PFE) within hours of reception, claiming the offer to be too low. A Raised [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-02T16:40:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"381\" \/>\n\t<meta property=\"og:image:height\" content=\"132\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Van Bettauer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Van Bettauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036\"},\"author\":{\"name\":\"Van Bettauer\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\"},\"headline\":\"Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer\",\"datePublished\":\"2014-05-02T16:40:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036\"},\"wordCount\":342,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg\",\"keywords\":[\"Astrazeneca Plc (ADR) (NYSE:AZN)\",\"NYSE:AZN\",\"NYSE:PFE\",\"Pfizer Inc (NYSE:PFE)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036\",\"name\":\"Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg\",\"datePublished\":\"2014-05-02T16:40:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg\",\"width\":381,\"height\":132},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\",\"name\":\"Van Bettauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"caption\":\"Van Bettauer\"},\"description\":\"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036","og_locale":"en_US","og_type":"article","og_title":"Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer - Wall Street PR","og_description":"Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0AstraZeneca plc (ADR) (NYSE:AZN) declined Pfizer Inc. (NYSE:PFE) within hours of reception, claiming the offer to be too low. A Raised [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-05-02T16:40:00+00:00","og_image":[{"width":381,"height":132,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg","type":"image\/jpeg"}],"author":"Van Bettauer","twitter_misc":{"Written by":"Van Bettauer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036"},"author":{"name":"Van Bettauer","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d"},"headline":"Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer","datePublished":"2014-05-02T16:40:00+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036"},"wordCount":342,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg","keywords":["Astrazeneca Plc (ADR) (NYSE:AZN)","NYSE:AZN","NYSE:PFE","Pfizer Inc (NYSE:PFE)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036","url":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036","name":"Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg","datePublished":"2014-05-02T16:40:00+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/AstraZeneca-plc.jpg","width":381,"height":132},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/astrazeneca-plc-adr-nyseazn-declined-pfizer-inc-nysepfes-106-5-billion-merger-offer-21036#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Astrazeneca Plc (ADR) (NYSE:AZN) Declined Pfizer Inc. (NYSE:PFE)\u2019S $106.5 Billion Merger Offer"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d","name":"Van Bettauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","caption":"Van Bettauer"},"description":"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/21036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=21036"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/21036\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/20478"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=21036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=21036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=21036"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=21036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}